Jadenu Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

90 mg: Light blue unscored ovaloid film-coated tablet with beveled edges, debossed with "NVR" on one side and "90" on a slight upward slope in between two debossed curved lines on the other side.
360 mg: Dark blue unscored ovaloid tablet film-coated with beveled edges, debossed with "NVR" on one side and "360" on a slight upward slope in between two debossed curved lines on the other side.
Proper name: Deferasirox.
Chemical name: 4-[3,5-bis-(2-hydroxyphenyl)-[1,2,4]-triazol-1-yl]benzoic acid.
Molecular formula and molecular mass: C₂₁H₁₅N₃O₄ and 373.37.
Physicochemical properties: Physical Form: white to slightly yellow powder.
Solubility: 0.4 mg/mL at pH 7.40, 25°C.
pH: The pH of a 0.5% (m/V) suspension of deferasirox in water at 22-25°C is 4.10.
Excipients/Inactive Ingredients: See Table 1.

Click on icon to see table/diagram/image

deferasirox

Manufacturer:

Novartis

Distributor:

DKSH

Four Star